SCHEMBL31639701

SCHEMBL31639701

Nc1ncnc2c1c(-c1noc(C3CC3)c1-c1ncc(C3CCNCC3)cn1)nn2C1CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 10/20 0.48
▸ SRC P12931 11/20 0.43
▸ FGFR1 P11362 2/20 0.41
▸ KDR P35968 10/20 0.40
▸ PIK3CD O00329 8/20 0.40
▸ ABL1 P00519 8/20 0.40
▸ EGFR P00533 8/20 0.40
▸ HCK P08631 8/20 0.40
▸ PIK3CA P42336 8/20 0.40
▸ PIK3CB P42338 8/20 0.40
▸ MTOR P42345 8/20 0.40
▸ PIK3CG P48736 8/20 0.40
▸ EPHB4 P54760 8/20 0.40
▸ PRKDC P78527 8/20 0.40
▸ PI4KB Q9UBF8 6/20 0.40
▸ JAK2 O60674 2/20 0.39
▸ PRKD3 O94806 2/20 0.39
▸ MAP4K4 O95819 2/20 0.39
▸ LCK P06239 2/20 0.39
▸ FYN P06241 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31639630 0.94 RET (0.45) RETSRCFGFR1KDRPIK3CD
SCHEMBL31639568 0.87 RET (0.43) RETSRCFGFR1KDRPIK3CD
Hydrochloric Acid SCHEMBL31640040 0.87 RET (0.51) RETSRCFGFR1KDRPIK3CD
Hydrochloric Acid SCHEMBL31639825 0.86 SRC (0.43) RETSRCFGFR1KDRPIK3CD
SCHEMBL31639349 0.85 RET (0.56) RETKDRHCKMAP2K2MAP2K1
Hydrochloric Acid SCHEMBL31639382 0.85 RET (0.55) RETKDRHCKMAP2K2MAP2K1
SCHEMBL31639311 0.84 RET (0.40) RET
SCHEMBL31640306 0.84 RET (0.42) RET
Hydrochloric Acid SCHEMBL31639440 0.83 RET (0.42) RET
SCHEMBL31640331 0.82 RET (0.42) RETSRCFGFR1KDRPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137605-A1 COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR C4 THERAPEUTICS, INC. (US) 2025-06-26 — — WO disclosed
Send feedback